Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Subject Index

Subject Index Subject Index Vol. 105, No. 3, 2001 Activated T cells 130 Immunotherapy 130 Allogeneic bone marrow transplantation Lung cancer 151 172 Mesenchymal stem cell 159 Aplastic anaemia 143 Multiple myeloma 125 Apoptosis 125 Myelosuppression 151 Autoimmune diseases 172 Neutropenia 151 Autologous transplantation 166, 179 Osteoblast 159 Bispecific antibodies 130 Osteogenesis 159 Bone marrow transplantation 156 Ovarian cancer 137 Breast cancer 137, 166 Pegylated molecule 151 CD34 137 Perforin 125 Cellular support 137 Peripheral blood stem cell mobilization 143 Clinical trials, design 188 Plasma exchange 156 Cytotoxicity 125 Portal venous injection 172 Dose intensity 137 Positive selection 137 Filgrastim 151 Preclinical studies 151 Granzyme B125 Purging 137 Hemolytic uremic syndrome 156 Stem cell 137 Hemopoiesis 143 – – factor 143 Hemopoietic stem cells 166 – – transplant 130 High-dose chemotherapy 166 Stromal cells 159, 172 Immune reconstitution 179 Survival curves 188 Immunoparesis 125 Thrombotic thrombocytopenic purpura Immunoselected CD34+ progenitors 179 156 © 2001 S. Karger AG, Basel ABC Fax + 41 61 306 12 34 E-Mail karger@karger.ch Accessible online at: www. karger.com www. karger.com/journals/aha http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Haematologica Karger

Subject Index

Acta Haematologica , Volume 105 (3): 1 – Jul 1, 2001

Loading next page...
 
/lp/karger/subject-index-d561i9PPVo

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Karger
Copyright
© 2001 S. Karger AG, Basel
ISSN
0001-5792
eISSN
1421-9662
DOI
10.1159/000046565
Publisher site
See Article on Publisher Site

Abstract

Subject Index Vol. 105, No. 3, 2001 Activated T cells 130 Immunotherapy 130 Allogeneic bone marrow transplantation Lung cancer 151 172 Mesenchymal stem cell 159 Aplastic anaemia 143 Multiple myeloma 125 Apoptosis 125 Myelosuppression 151 Autoimmune diseases 172 Neutropenia 151 Autologous transplantation 166, 179 Osteoblast 159 Bispecific antibodies 130 Osteogenesis 159 Bone marrow transplantation 156 Ovarian cancer 137 Breast cancer 137, 166 Pegylated molecule 151 CD34 137 Perforin 125 Cellular support 137 Peripheral blood stem cell mobilization 143 Clinical trials, design 188 Plasma exchange 156 Cytotoxicity 125 Portal venous injection 172 Dose intensity 137 Positive selection 137 Filgrastim 151 Preclinical studies 151 Granzyme B125 Purging 137 Hemolytic uremic syndrome 156 Stem cell 137 Hemopoiesis 143 – – factor 143 Hemopoietic stem cells 166 – – transplant 130 High-dose chemotherapy 166 Stromal cells 159, 172 Immune reconstitution 179 Survival curves 188 Immunoparesis 125 Thrombotic thrombocytopenic purpura Immunoselected CD34+ progenitors 179 156 © 2001 S. Karger AG, Basel ABC Fax + 41 61 306 12 34 E-Mail karger@karger.ch Accessible online at: www. karger.com www. karger.com/journals/aha

Journal

Acta HaematologicaKarger

Published: Jul 1, 2001

There are no references for this article.